CPAP or BiPAP for Motion Mitigation During Radiotherapy

When using highly conformal radiotherapy techniques, such as proton therapy, a controlled breathing pattern and a minimal breathing amplitude could greatly benefit the treatment of mobile tumors. This reduction in tumor motion may be achieved with the use of a ventilator that is able to regulate and modulate the breathing pattern. CPAP provides a constant level of positive airway pressure. Compared to spontaneous breathing, the use of CPAP increased lung volume and can result in a significant decrease in tumor movement and a significant decrease in both mean lung and mean heart radiation dose.

Trial Details

NCT ID
NCT04986293
Phase
NA
Sponsor
University Medical Center Groningen
Status
RECRUITING
Cancer Type
Lymphoma
Interventions
  • CPAP
Locations (sample)
  • Groningen, Provincie Groningen, Netherlands|53.21917,6.56667

Key Eligibility Criteria

  • Age ≥18 years
  • Stage III/IV (N)SCLC, esophageal cancer or malignant lymphoma that will be treated with curative intent
  • Written informed consent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lymphoma Trials on Trialify →